Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unusual enantioselective cytoplasm-to-nucleus translocation and photosensitization of the chiral Ru(II) cationic complex via simple ion-pairing with lipophilic weak acid counter-anions. | Nucleic Acids Res | 2023 | 36938880 | PubTator, text mining | PubMed |
| IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact. | Blood | 2023 | 36929172 | PubTator, text mining | PubMed |
| SOHO State-of-the-Art Updates and Next Questions | BCMA-Directed CAR T-Cells: Early Results and Future Directions. | Clin Lymphoma Myeloma Leuk | 2023 | 36925390 | PubTator, text mining | PubMed |
| Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4. | Bioorg Chem | 2023 | 36924654 | PubTator, text mining | PubMed |
| Role of p53 in breast cancer progression: An insight into p53 targeted therapy. | Theranostics | 2023 | 36923534 | PubTator, text mining | PubMed |
| Mapping the energy landscape of PROTAC-mediated protein-protein interactions. | Comput Struct Biotechnol J | 2023 | 36923472 | PubTator, text mining | PubMed |
| Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. | J Transl Med | 2023 | 36922828 | PubTator, text mining | PubMed |
| Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA. | J Virus Erad | 2023 | 36911658 | PubTator, text mining | PubMed |
| PROTACs: Walking through hematological malignancies. | Front Pharmacol | 2023 | 36909156 | PubTator, text mining | PubMed |
| Accessing three-branched high-affinity cereblon ligands for molecular glue and protein degrader design. | RSC Chem Biol | 2023 | 36908700 | PubTator, text mining | PubMed |
| Protein-protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction. | RSC Chem Biol | 2023 | 36908699 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands. | Bioorg Med Chem | 2023 | 36906965 | PubTator, text mining | PubMed |
| Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. | Cancer Cell | 2023 | 36898380 | PubTator, text mining | PubMed |
| Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer. | EBioMedicine | 2023 | 36893587 | PubTator, text mining | PubMed |
| Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma. | Biomark Res | 2023 | 36890597 | PubTator, text mining | PubMed |
| A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects. | Clin Pharmacol | 2023 | 36880014 | PubTator, text mining | PubMed |
| Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. | Blood Cancer J | 2023 | 36878906 | PubTator, text mining | PubMed |
| PROTAC Linkerology Leads to an Optimized Bivalent Chemical Degrader of Polycomb Repressive Complex 2 (PRC2) Components. | ACS Chem Biol | 2023 | 36877831 | PubTator, text mining | PubMed |
| Severe Lenalidomide-Associated Hyperbilirubinemia. | Cureus | 2023 | 36874759 | PubTator, text mining | PubMed |
| Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury. | J Biomed Sci | 2023 | 36872339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=41